Also trades as: CDTTW (NASDAQ) · $vol 0M
CDT NASDAQ
CDT Equity Inc.
1W: -42.0%
1M: -62.8%
3M: +32.2%
YTD: -14.6%
1Y: -97.3%
3Y: -100.0%
$1.23
+0.03 (+2.50%)
Weekly Expected Move ±13.7%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$6.0M
52W Range1.18-1130
Volume265,832
Avg Volume85,586
Beta1.57
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAndrew Regan
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-28
Websiteconduitpharma.com
4581 Tamiami Trail North
Naples, FL 34103
US
Naples, FL 34103
US
646 491 9132
About CDT Equity Inc.
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Latest News
12 Health Care Stocks Moving In Monday's After-Market Session
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
12 Health Care Stocks Moving In Friday's After-Market Session
What's Going On With CDT Equity Shares On Monday?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Regan Andrew | A-Award | 100,000 | $1.90 | 2026-05-13 |
| Olsen Ulrik K | 0 | — | 2026-04-27 | |
| Regan Andrew | A-Award | 147,401 | — | 2026-03-24 |
| Taylor Mark Andrew | J-Other | 51,420,358 | — | 2026-03-17 |
| Taylor Mark Andrew | J-Other | 51,161,318 | — | 2026-03-17 |